|
| 1 |
Laparoscopic surgery contributes to a decrease in short-term complications in surgical ulcerative colitis patients during 2008–2017: a multicenter retrospective study in China
Zerong Cai, Xiaosheng He, Jianfeng Gong, Peng Du, Wenjian Meng, Wei Zhou, Jinbo Jiang, Bin Wu, Weitang Yuan, Qi Xue, Lianwen Yuan, Jinhai Wang, Jiandong Tai, Jie Liang, Weiming Zhu, Ping Lan, Xiaojian Wu
Intest Res.2023;21(2):235-243. Published online 2022 December 2
DOI: http://dx.doi.org/10.5217/ir.2022.00012
|
|
| 2 |
Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
Intest Res.2023;21(2):252-265. Published online 2022 December 2
DOI: http://dx.doi.org/10.5217/ir.2022.00092
|
|
| 3 |
Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale
Intest Res.2023;21(3):392-405. Published online 2022 December 2
DOI: http://dx.doi.org/10.5217/ir.2022.00094
|
|
| 4 |
Recent advances in surveillance colonoscopy for dysplasia in inflammatory bowel disease
Soo-Young Na, Won Moon
Clin Endosc.2022;55(6):726-735. Published online 2022 November 18
DOI: http://dx.doi.org/10.5946/ce.2022.132
|
|
| 5 |
Clostridioides Infection in Patients with Inflammatory Bowel Disease
Mi Rae Lee, Eun Soo Kim
|
|
| 6 |
Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis
Intest Res.2022;20(4):495-505. Published online 2022 August 8
DOI: http://dx.doi.org/10.5217/ir.2022.00017
|
|
| 7 |
Clinical spectrum of elderly-onset inflammatory bowel disease in India
Yogesh Kumar Gupta, Arshdeep Singh, Vikram Narang, Vandana Midha, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Namita Bansal, Madeline Vithya Barnaba Durairaj, Amit Kumar Dutta, Ajit Sood
Intest Res.2023;21(2):216-225. Published online 2022 August 8
DOI: http://dx.doi.org/10.5217/ir.2021.00177
|
|
| 8 |
Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, A Hyeon Kim, Kwang Woo Kim, Jun Won Park, Hyun Jung Lee, Hyoun Woo Kang, Jong Pil Im, Young Soo Park, Joo Sung Kim
Intest Res.2023;21(2):244-251. Published online 2022 August 8
DOI: http://dx.doi.org/10.5217/ir.2022.00057
|
|
| 9 |
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
Intest Res.2023;21(1):61-87. Published online 2022 May 31
DOI: http://dx.doi.org/10.5217/ir.2022.00007
|
|
| 10 |
One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
Yuichi Matsuno, Takehiro Torisu, Junji Umeno, Hiroki Shibata, Atsushi Hirano, Yuta Fuyuno, Yasuharu Okamoto, Shin Fujioka, Keisuke Kawasaki, Tomohiko Moriyama, Tomohiro Nagasue, Keizo Zeze, Yoichiro Hirakawa, Shinichiro Kawatoko, Yutaka Koga, Yoshinao Oda, Motohiro Esaki, Takanari Kitazono
Intest Res.2022;20(2):260-268. Published online 2022 April 29
DOI: http://dx.doi.org/10.5217/ir.2021.00124
|
|
| 11 |
Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
Intest Res.2022;20(4):452-463. Published online 2022 March 11
DOI: http://dx.doi.org/10.5217/ir.2021.00125
|
|
| 12 |
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe
Intest Res.2023;21(1):110-125. Published online 2022 March 11
DOI: http://dx.doi.org/10.5217/ir.2021.00143
|
|
| 13 |
Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, Masato Hoshi, Shoko Arai
Intest Res.2023;21(1):88-99. Published online 2022 March 11
DOI: http://dx.doi.org/10.5217/ir.2021.00154
|
|
| 14 |
Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study
Avnish Kumar Seth, Priti Jain
Intest Res.2022;20(2):251-259. Published online 2022 February 8
DOI: http://dx.doi.org/10.5217/ir.2021.00069
|
|
| 15 |
Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
Ajit Sood, Ramit Mahajan, Arshdeep Singh, Vandana Midha, Varun Mehta
Intest Res.2022;20(3):297-302. Published online 2022 February 8
DOI: http://dx.doi.org/10.5217/ir.2021.00099
|
|
| 16 |
Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study
Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal
Intest Res.2022;20(4):445-451. Published online 2022 February 8
DOI: http://dx.doi.org/10.5217/ir.2021.00106
|
|
| 17 |
비전형적 궤양성 대장염 환자에서 5-아미노살리실산에 의해 유발된 심근염
Hyo Yeop Song, Geom Seog Seo
|
|
| 18 |
Artificial intelligence for endoscopy in inflammatory bowel disease
Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
Intest Res.2022;20(2):165-170. Published online 2022 January 7
DOI: http://dx.doi.org/10.5217/ir.2021.00079
|
|
| 19 |
Landscape of inflammatory bowel disease in Singapore
Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
Intest Res.2022;20(3):291-296. Published online 2022 January 7
DOI: http://dx.doi.org/10.5217/ir.2021.00089
|
|
| 20 |
Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
Intest Res.2022;20(3):329-341. Published online 2021 August 4
DOI: http://dx.doi.org/10.5217/ir.2021.00032
|
|
